Literature DB >> 23864439

Epigenetics primer: why the clinician should care about epigenetics.

Julio D Duarte1.   

Abstract

Epigenetics describes heritable alterations of gene expression that do not involve DNA sequence variation and are changeable throughout an organism's lifetime. Not only can epigenetic status influence drug response, but it can also be modulated by drugs. In this review, the three major epigenetic mechanisms are described: covalent DNA modification, histone protein modification, and regulation by noncoding RNA. Further, this review describes how drug therapy can influence, and be influenced by, these mechanisms. Drugs with epigenetic mechanisms are already in use, with many more likely to be approved within the next few years. As the understanding of epigenetic processes improves, so will the ability to use these data in the clinic to improve patient care.
© 2013 Pharmacotherapy Publications, Inc.

Entities:  

Keywords:  DNA methylation; epigenetics; epigenomics; histone modifications; miRNA; pharmacoepigenetics

Mesh:

Substances:

Year:  2013        PMID: 23864439     DOI: 10.1002/phar.1325

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  4 in total

1.  Primer in Genetics and Genomics, Article 6: Basics of Epigenetic Control.

Authors:  Kristen L Fessele; Fay Wright
Journal:  Biol Res Nurs       Date:  2017-11-23       Impact factor: 2.522

2.  The tissue is the issue: improved methylome analysis from paraffin-embedded tissues by application of the HOPE technique.

Authors:  Sebastian Marwitz; Julia Kolarova; Martin Reck; Niels Reinmuth; Christian Kugler; Ines Schädlich; Andrea Haake; Peter Zabel; Ekkehard Vollmer; Reiner Siebert; Torsten Goldmann; Ole Ammerpohl
Journal:  Lab Invest       Date:  2014-06-16       Impact factor: 5.662

3.  Association of GWAS-Supported Variants rs556621 on Chromosome 6p21.1 with Large Artery Atherosclerotic Stroke in a Southern Chinese Han Population.

Authors:  Hao Zhang; Qijin Zhai; Zhizhong Zhang; Biyang Cai; Huan Cai; Shuyu Zhou; Lingli Sun; Yi Xie; Deyan Kong; Zongliang Xu; Kunxiong Yuan; Wenjie Zi; Xinfeng Liu; Gelin Xu
Journal:  Neuromolecular Med       Date:  2016-08-27       Impact factor: 3.843

4.  DNA methylation alterations in muscle of critically ill patients.

Authors:  Lisa Van Dyck; Fabian Güiza; Inge Derese; Lies Pauwels; Michaël P Casaer; Greet Hermans; Pieter J Wouters; Greet Van den Berghe; Ilse Vanhorebeek
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-03-11       Impact factor: 12.063

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.